Accéder au contenu
Merck

Mismatched perfusion defects secondary to recent methyl methacrylate embolization.

Clinical nuclear medicine (2012-12-18)
Garima Agrawal, Chadwick L Wright, Nicholas G Rhodes, Akash Sharma
RÉSUMÉ

Methyl methacrylate (MMA) pulmonary embolism is a serious potential complication of percutaneous vertebroplasty. We present a case of a 28-year-old man who presented to an outside institution with pleuritic chest pain after MMA vertebroplasty of the T11 thoracic vertebra for chronic back ache secondary to a previous traumatic fracture. Multifocal MMA pulmonary embolism was identified on CT. The patient was referred to our institution following a wedge resection for pulmonary infarction. V/Q scintigraphy was performed and demonstrated normal ventilation with multiple mismatched perfusion defects bilaterally. Patient subsequently underwent central and bilateral segmental pulmonary embolectomies.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Méthacrylate de méthyle, contains ≤30 ppm MEHQ as inhibitor, 99%
Sigma-Aldrich
Méthacrylate de méthyle, 99%, stabilized
Supelco
Methyl methacrylate solution, certified reference material, 1000 μg/mL in methanol
Sigma-Aldrich
Méthacrylate de méthyle, SAJ first grade, ≥99.0%